BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 23917208)

  • 41. Sensitivity of orexin-A binding to phospholipase C inhibitors, neuropeptide Y, and secretin.
    Kane JK; Tanaka H; Parker SL; Yanagisawa M; Li MD
    Biochem Biophys Res Commun; 2000 Jun; 272(3):959-65. PubMed ID: 10860858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Eating, sleeping and rewarding: orexin receptors and their antagonists.
    Bingham MJ; Cai J; Deehan MR
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):551-9. PubMed ID: 17002215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Orexin A and B in vitro modify orexins receptors expression and gonadotropins secretion of anterior pituitary cells of proestrous rats.
    Cataldi NI; Lux Lantos VA; Libertun C
    Regul Pept; 2014 Jan; 188():25-30. PubMed ID: 24333629
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Orexin-stimulated MAP kinase cascades are activated through multiple G-protein signalling pathways in human H295R adrenocortical cells: diverse roles for orexins A and B.
    Ramanjaneya M; Conner AC; Chen J; Kumar P; Brown JE; Jöhren O; Lehnert H; Stanfield PR; Randeva HS
    J Endocrinol; 2009 Aug; 202(2):249-61. PubMed ID: 19460850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A role for lateral hypothalamic orexin neurons in reward seeking.
    Harris GC; Wimmer M; Aston-Jones G
    Nature; 2005 Sep; 437(7058):556-9. PubMed ID: 16100511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hypothalamic neuropeptides implicated in the regulation of sleep/wakefulness states].
    Sakurai T
    Brain Nerve; 2012 Jun; 64(6):629-37. PubMed ID: 22647470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interactions of orexins/hypocretins with adrenocortical functions.
    Kagerer SM; Jöhren O
    Acta Physiol (Oxf); 2010 Mar; 198(3):361-71. PubMed ID: 19719797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Orexin receptor expression in the hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal axes of free-living European beavers (Castor fiber L.) in different periods of the reproductive cycle.
    Czerwinska J; Chojnowska K; Kaminski T; Bogacka I; Smolinska N; Kaminska B
    Gen Comp Endocrinol; 2017 Jan; 240():103-113. PubMed ID: 27664717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of sleep-wake patterns in a novel transgenic mouse line overexpressing human prepro-orexin/hypocretin.
    Mäkelä KA; Wigren HK; Zant JC; Sakurai T; Alhonen L; Kostin A; Porkka-Heiskanen T; Herzig KH
    Acta Physiol (Oxf); 2010 Mar; 198(3):237-49. PubMed ID: 20003098
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Orexins in the regulation of the hypothalamic-pituitary-adrenal axis.
    Spinazzi R; Andreis PG; Rossi GP; Nussdorfer GG
    Pharmacol Rev; 2006 Mar; 58(1):46-57. PubMed ID: 16507882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blockade of orexin-1 receptors in the ventral tegmental area could attenuate the lateral hypothalamic stimulation-induced potentiation of rewarding properties of morphine.
    Zarepour L; Fatahi Z; Sarihi A; Haghparast A
    Neuropeptides; 2014 Jun; 48(3):179-85. PubMed ID: 24793540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Role of hypothalamic orexin in drug addiction].
    Han J; Li YH; Bai YJ; Sui N
    Sheng Li Ke Xue Jin Zhan; 2007 Oct; 38(4):327-30. PubMed ID: 18232303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target.
    Alain C; Pascal N; Valérie G; Thierry V
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Localization of orexin B and orexin-2 receptor in the rat epididymis.
    Liguori G; Tafuri S; Miyoshi C; Yanagisawa M; Squillacioti C; De Pasquale V; Mirabella N; Vittoria A; Costagliola A
    Acta Histochem; 2018 Apr; 120(3):292-297. PubMed ID: 29496265
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroendocrine regulatory peptide-2 regulates feeding behavior via the orexin system in the hypothalamus.
    Toshinai K; Yamaguchi H; Kageyama H; Matsuo T; Koshinaka K; Sasaki K; Shioda S; Minamino N; Nakazato M
    Am J Physiol Endocrinol Metab; 2010 Sep; 299(3):E394-401. PubMed ID: 20551287
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of Orexin-A Treatment on Food Intake, Energy Metabolism and Body Weight in Mice.
    Blais A; Drouin G; Chaumontet C; Voisin T; Couvelard A; Even PC; Couvineau A
    PLoS One; 2017; 12(1):e0169908. PubMed ID: 28085909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Orexins and their receptors: structural aspects and role in peripheral tissues.
    Voisin T; Rouet-Benzineb P; Reuter N; Laburthe M
    Cell Mol Life Sci; 2003 Jan; 60(1):72-87. PubMed ID: 12613659
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats.
    Akanmu MA; Honda K
    Brain Res; 2005 Jun; 1048(1-2):138-45. PubMed ID: 15919057
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of orexins/hypocretins on neuronal activity in the paraventricular nucleus of the thalamus in rats in vitro.
    Ishibashi M; Takano S; Yanagida H; Takatsuna M; Nakajima K; Oomura Y; Wayner MJ; Sasaki K
    Peptides; 2005 Mar; 26(3):471-81. PubMed ID: 15652654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypothalamic orexin--a neurons are involved in the response of the brain stress system to morphine withdrawal.
    Laorden ML; Ferenczi S; Pintér-Kübler B; González-Martín LL; Lasheras MC; Kovács KJ; Milanés MV; Núñez C
    PLoS One; 2012; 7(5):e36871. PubMed ID: 22590628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.